✦ LIBER ✦

A randomized study of VP-16/cisplatin/chest RT ± GM-CSF in limited stage Small Cell Lung Cancer (SCLC): Preliminary results of a Southwest Oncology Group (SWOG) study

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

88 Oral etoposide (VP-16) every 3 wks. o

✍ Bork, E.; Hirsch, F.; Jeppesen, N.; Lassen, U.; Vallentin, S.; Østerlind, K.; Me 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 132 KB

266 A phase II study of VP-16 plus ifosf

✍ Sandler, A.B.; Ansari, R.; Fisher, W.; Gonin, R.; Levy, R.; Einhorn, L.H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase II study of cisplatin, etoposide

✍ Kelly, K; Bunn, P.A; Lovato, L; Crowley, J; Livingston, R.B; Gandara, D.R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A randomized phase III study of irinotec

✍ Negoro, S; Noda, K; Nishiwaki, Y; Kawahara, M; Tamura, T; Sugiura, T; Yokayama, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

A phase III study of VP16 plus cisplatin

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 98 KB

P-774 Phase II study of cisplatin plus e

✍ Kashii, T.; Saito, H.; Negoro, S.; Takada, Y.; Ichinose, Y.; Matsui, K.; Eguchi, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB